{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:16:28Z","timestamp":1788182188580,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","award":["PNC24-260845"],"award-info":[{"award-number":["PNC24-260845"]}],"id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK056338"],"award-info":[{"award-number":["DK056338"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["24IPA1267122"],"award-info":[{"award-number":["24IPA1267122"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007863","name":"Rice University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","award":["S10OD030414"],"award-info":[{"award-number":["S10OD030414"]}],"id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","award":["P30 CA125123"],"award-info":[{"award-number":["P30 CA125123"]}],"id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","award":["P50HD103555"],"award-info":[{"award-number":["P50HD103555"]}],"id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","award":["P30 DK056338"],"award-info":[{"award-number":["P30 DK056338"]}],"id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023456","name":"Defeat Duchenne Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK124477"],"award-info":[{"award-number":["DK124477"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL132840"],"award-info":[{"award-number":["HL132840"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U42OD026645"],"award-info":[{"award-number":["U42OD026645"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT183583"],"award-info":[{"award-number":["PJT183583"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210116"],"award-info":[{"award-number":["RP210116"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymthe.2026.02.049","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:09:32Z","timestamp":1772557772000},"page":"3334-3352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytosine base editing of LPA in transgenic mice averts large deletions"],"prefix":"10.1016","volume":"34","author":[{"given":"Marcel A.","family":"Chuecos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhvi M.","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usosa","family":"Too-Chiobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Betancourth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Walkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biana","family":"Godin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Assini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna J.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlys L.","family":"Koschinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1703-5125","authenticated-orcid":false,"given":"William R.","family":"Lagor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.02.049_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A New Serum Type System in Man--the Lp System","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.ymthe.2026.02.049_bib2","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI115645","article-title":"Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease","volume":"89","author":"Sandholzer","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.02.049_bib3","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib4","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib5","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2026.02.049_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1042\/BCJ20240037","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"481","author":"Boffa","year":"2024","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2026.02.049_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF00201550","article-title":"Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups","volume":"86","author":"Sandholzer","year":"1991","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.02.049_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1172\/JCI113093","article-title":"Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma","volume":"80","author":"Utermann","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.02.049_bib9","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/ATVBAHA.116.308011","article-title":"Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United States","volume":"36","author":"Varvel","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"404","key":"10.1016\/j.ymthe.2026.02.049_bib75","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"836","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.02.049_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100886","article-title":"Lipoprotein (a) testing patterns among subjects with a measured lipid panel: The Mayo Clinic experience","volume":"20","author":"Manzato","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jacl.2024.11.007","article-title":"Lipoprotein(a) levels in a population with clinical atherosclerotic cardiovascular disease in the United States: A subanalysis from the Lp(a)HERITAGE study","volume":"19","author":"Shapiro","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072024","article-title":"Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?","volume":"12","author":"Enkhmaa","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ymthe.2026.02.049_bib13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/eurjpc\/zwab171","article-title":"Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis","volume":"29","author":"de Boer","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib14","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","article-title":"Statin therapy increases lipoprotein(a) levels","volume":"41","author":"Tsimikas","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2026.02.049_bib15","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11883-020-00886-0","article-title":"Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia","volume":"22","author":"Pokrovsky","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.ymthe.2026.02.049_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) Reduction in Persons with Cardiovascular Disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa2415818","article-title":"Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)","volume":"392","author":"Nissen","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib20","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.2024.21957","article-title":"Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial","volume":"332","author":"Nissen","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2026.02.049_bib21","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease","volume":"387","author":"O'Donoghue","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2025.03.019","article-title":"Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)","volume":"287","author":"Cho","year":"2025","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ymthe.2026.02.049_bib23","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1093\/eurheartj\/ehaf411","article-title":"Gene therapy and genome editing for lipoprotein disorders","volume":"46","author":"Gurevitz","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2026.02.049_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.02.049_bib26","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1073\/pnas.94.22.11992","article-title":"Convergent evolution of apolipoprotein(a) in primates and hedgehog","volume":"94","author":"Lawn","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.049_bib27","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/ATVBAHA.114.303462","article-title":"A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk","volume":"34","author":"Kyriakou","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004494","article-title":"Distribution and medical impact of loss-of-function variants in the Finnish founder population","volume":"10","author":"Lim","year":"2014","journal-title":"Plos Genet."},{"key":"10.1016\/j.ymthe.2026.02.049_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.omtm.2022.10.009","article-title":"LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study","volume":"27","author":"Doerfler","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.02.049_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymthe.2024.11.020","article-title":"Lipid nanoparticle delivery of TALEN mRNA targeting LPA causes gene disruption and plasma lipoprotein(a) reduction in transgenic mice","volume":"33","author":"Garcia","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.049_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41551-024-01277-5","article-title":"Large DNA deletions occur during DNA repair at 20-fold lower frequency for base editors and prime editors than for Cas9 nucleases","volume":"9","author":"Hwang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.02.049_bib32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/crispr.2019.0006","article-title":"CRISPR-Cas9 Causes Chromosomal Instability and Rearrangements in Cancer Cell Lines, Detectable by Cytogenetic Methods","volume":"2","author":"Rayner","year":"2019","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.02.049_bib35","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-019-09006-2","article-title":"CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations","volume":"10","author":"Cullot","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.049_bib36","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2026.02.049_bib37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12859-018-2585-4","article-title":"Web-based design and analysis tools for CRISPR base editing","volume":"19","author":"Hwang","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.02.049_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.02.049_bib39","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/s41467-024-45969-7","article-title":"Phage-assisted evolution of highly active cytosine base editors with enhanced selectivity and minimal sequence context preference","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.049_bib40","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1073\/pnas.93.24.13565","article-title":"A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal","volume":"93","author":"Parks","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.049_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymthe.2005.03.001","article-title":"Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors","volume":"12","author":"Brunetti-Pierri","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.049_bib42","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1074\/jbc.272.4.2176","article-title":"Production and characterization of recombinant human plasminogen(S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease","volume":"272","author":"Horrevoets","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.02.049_bib43","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.122.062132","article-title":"Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models","volume":"147","author":"Lee","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.02.049_bib45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.049_bib48","article-title":"Dual SORT LNPs for multi-organ base editing","author":"Kim","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","article-title":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain","volume":"13","author":"Madisen","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2026.02.049_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: A bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.049_bib51","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41591-024-03466-w","article-title":"In vivo base editing extends lifespan of a humanized mouse model of prion disease","volume":"31","author":"An","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib52","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.049_bib53","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","article-title":"AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9","volume":"28","author":"Li","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.049_bib54","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.1073\/pnas.92.18.8483","article-title":"Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals","volume":"92","author":"Yamanaka","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.049_bib55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.02.049_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.02.049_bib57","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41591-025-03508-x","article-title":"A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels","volume":"31","author":"Tremblay","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib58","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/bi00234a029","article-title":"Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells","volume":"30","author":"Koschinsky","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2026.02.049_bib59","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.omtm.2021.04.011","article-title":"Targeting the Apoa1 locus for liver-directed gene therapy","volume":"21","author":"De Giorgi","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.02.049_bib60","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-60327-369-5_13","article-title":"Adeno-associated viruses as liver-directed gene delivery vehicles: focus on lipoprotein metabolism","volume":"1027","author":"Lagor","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.02.049_bib61","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.049_bib62","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ymthe.2004.06.1013","article-title":"Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material","volume":"10","author":"Palmer","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.049_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.05.019","article-title":"High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner","volume":"384","author":"Assini","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymthe.2026.02.049_bib64","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.02.049_bib65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/crispr.2018.0014","article-title":"EditR: A Method to Quantify Base Editing from Sanger Sequencing","volume":"1","author":"Kluesner","year":"2018","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.02.049_bib66","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.02.049_bib67","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1038\/s41467-023-41004-3","article-title":"Prediction of base editor off-targets by deep learning","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.049_bib68","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2584","article-title":"VSEARCH: a versatile open source tool for metagenomics","volume":"4","author":"Rognes","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.ymthe.2026.02.049_bib69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1101\/gr.214270.116","article-title":"Fast and accurate de novo genome assembly from long uncorrected reads","volume":"27","author":"Vaser","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2026.02.049_bib70","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1038\/s41467-019-11321-7","article-title":"Standard screening methods underreport AAV-mediated transduction and gene editing","volume":"10","author":"Lang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.049_bib71","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jtha.2025.10.009","article-title":"Lipoprotein(a) prolongs ex vivo plasma clot lysis times through effects on clot formation rate and fibrin structure","volume":"24","author":"Clark","year":"2026","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2026.02.049_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12771","article-title":"A novel ex vivo approach for measuring plasminogen activation upon established plasma clots","volume":"6","author":"Palazzolo","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2026.02.049_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk3920","article-title":"In vivo expansion of gene-targeted hepatocytes through transient inhibition of an essential gene","volume":"17","author":"De Giorgi","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.049_bib74","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1194\/jlr.RA120001006","article-title":"Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase","volume":"61","author":"De Giorgi","year":"2020","journal-title":"J. Lipid Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:20:06Z","timestamp":1788178806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1525001626001784"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.049","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytosine base editing of LPA in transgenic mice averts large deletions","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}